Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
financing
5
×
life sciences
national blog main
boston blog main
startups
venture capital
boston
boston top stories
clinical trials
drug development
fda
funding
san diego blog main
san diego top stories
series a
vc
20/20 healthcare partners
abbvie
accent therapeutics
access biotechnology
access industries
aducanumab
akero therapeutics
alnylam
alzheimer's disease
amblyotech
amgen ventures
amyotrophic lateral sclerosis
anemia
anthony despasqua
apellis pharmaceuticals
aragon pharmaceuticals
arena pharmaceuticals
artie suckow
asklepios biopharmaceutical
atlas ventures
bioeurope
biogen
biomarin pharmaceutical
What
new
5
×
advance
diseases
drugs
medicine
medicines
activity
anemia
approach
approvals
associated
bags
bio
biogen
biologics
biotechs
blood
body
capital
carry
cells
clamped
companies
considered
covid
delays
deliver
develop
developing
device
dialysis
disc
disease
dtx
economic
enclear
fast
fda
harmful
having
Language
unset
5
×
Current search:
financing
×
new
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments